Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company's segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials. The Academic Research segment includes cognitive test products for researchers working in a non-regulated environment, typically in academia. The Healthcare Technology segment includes medical software for use in healthcare delivery settings. The Company is a provider of validated touchscreen cognitive assessments for clinical trials. The Company's product, CANTAB Mobile is a Class II medical device, used to identify patients exhibiting the early signs of Alzheimer's disease. It also offers Cantab Insight for dementia assessment in secondary care.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:COG
- CUSIP: N/A
- Web: N/A
- Market Cap: £23.67 million
- Outstanding Shares: 20,317,000
- 50 Day Moving Avg: GBX 108.13
- 200 Day Moving Avg: GBX 82.37
- 52 Week Range: GBX 30 - GBX 125
Sales & Book Value:
- Trailing P/E Ratio: 83.21
- P/E Growth: 0.00
- Annual Revenue: £6.88 million
- Price / Sales: 3.44
- Book Value: GBX 0.14 per share
- Price / Book: 8.32
- Average Volume: 36,951 shs.
Frequently Asked Questions for Cambridge Cognition Holdings PLC (LON:COG)
What is Cambridge Cognition Holdings PLC's stock symbol?
Cambridge Cognition Holdings PLC trades on the London Stock Exchange (LON) under the ticker symbol "COG."
Where is Cambridge Cognition Holdings PLC's stock going? Where will Cambridge Cognition Holdings PLC's stock price be in 2017?
1 brokerages have issued twelve-month price targets for Cambridge Cognition Holdings PLC's shares. Their forecasts range from GBX 130 to GBX 130. On average, they expect Cambridge Cognition Holdings PLC's share price to reach GBX 130 in the next twelve months. View Analyst Ratings for Cambridge Cognition Holdings PLC.
Who are some of Cambridge Cognition Holdings PLC's key competitors?
Some companies that are related to Cambridge Cognition Holdings PLC include Bushveld Minerals Limited (BMN), Applied Graphene Materials PLC (AGM), Bonmarche Holdings PLC (BON), ITM Power plc (ITM), Seeing Machines Limited (SEE), Sanderson Group plc (SND), Watchstone Group PLC (QPP), Atlantis Resources Ltd (ARL), Management Consulting Group PLC (MMC), Wentworth Resources Ltd (WRL), Cerillion PLC (CER), Waterman Group plc (WTM), Wolf Minerals Limited (WLFE), Kromek Group PLC (KMK), Taptica International Ltd (MARI), Trans-Siberian Gold plc (TSG), Plant Health Care plc (PHC) and AFC Energy plc (AFC).
How do I buy Cambridge Cognition Holdings PLC stock?
Shares of Cambridge Cognition Holdings PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Cambridge Cognition Holdings PLC stock cost?
One share of Cambridge Cognition Holdings PLC stock can currently be purchased for approximately GBX 116.50.
Consensus Ratings for Cambridge Cognition Holdings PLC (LON:COG) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||GBX 130|
Analysts' Ratings History for Cambridge Cognition Holdings PLC (LON:COG)
(Data available from 5/24/2015 forward)
|3/31/2017||Dowgate Capital||Initiated Coverage||Buy|
|3/29/2017||FinnCap||Boost Price Target||Corporate||GBX 115 -> GBX 130|
Earnings History for Cambridge Cognition Holdings PLC (LON:COG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Cambridge Cognition Holdings PLC (LON:COG)
Current Year EPS Consensus Estimate: $0.64 EPS
Dividend History for Cambridge Cognition Holdings PLC (LON:COG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Cambridge Cognition Holdings PLC (LON:COG)Insider Trades by Quarter for Cambridge Cognition Holdings PLC (LON:COG)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/29/2017||Nicholas Anthony Kerton||Insider||Sell||150,000||GBX 78||£117,000|
|5/5/2016||Powell,Steven John||Insider||Buy||30,000||GBX 36||£10,800|
|6/5/2015||Andrew Damian Blackwell||Insider||Sell||150,000||GBX 80||£120,000|
Headline Trends for Cambridge Cognition Holdings PLC (LON:COG)
Latest Headlines for Cambridge Cognition Holdings PLC (LON:COG)
Cambridge Cognition Holdings PLC (COG) Chart for Wednesday, May, 24, 2017